首页|血清AIM2、CDC42联合检测对急性心肌梗死患者发生MACE的预测价值

血清AIM2、CDC42联合检测对急性心肌梗死患者发生MACE的预测价值

扫码查看
目的 分析血清黑色素瘤缺乏因子2(AIM2)、细胞分裂周期蛋白42(CDC42)联合检测对急性心肌梗死(AMI)患者发生主要不良心血管事件(MACE)的预测价值.方法 选取2019年2月至2021年12月在北京航天总医院进行经皮冠状动脉介入术治疗的108例AMI患者纳入AMI组,另选取同期在北京航天总医院体检的60例健康人为对照组.收集患者基线资料,采用酶联免疫吸附试验检测血清AIM2、CDC42水平,并对AMI患者进行为期6个月的随访,根据随访期间是否发生MACE,将其分为MACE组和非MACE组.采用Spearman相关分析AMI患者血清AIM2、CDC42水平与心功能Killip分级的相关性.采用多因素Logistic回归分析AMI患者发生MACE的影响因素.绘制受试者工作特征(ROC)曲线分析血清AIM2、CDC42单独及联合检测对AMI患者发生MACE的预测价值.结果 AMI组血清AIM2水平高于对照组,CDC42水平低于对照组,差异均有统计学意义(P<0.05).MACE组有29例患者,非MACE组有79例患者.MACE组血清AIM2水平高于非MACE组,血清CDC42水平低于非MACE组,差异均有统计学意义(P<0.05).相比于Killip分级为Ⅰ~Ⅱ级AMI患者,Killip分级为Ⅲ~Ⅳ级AMI患者血清AIM2水平较高,CDC42水平较低,差异均有统计学意义(P<0.05).Spearman相关分析结果显示,AMI患者血清AIM2水平与Killip分级呈正相关(rs=0.667,P<0.001),血清 CDC42 水平与 Killip 分级呈负相关(rs=-0.712,P<0.001).多因素 Lo-gistic 回归分析结果显示,血清AIM2水平升高是AMI患者发生MACE的独立危险因素,血清CDC42水平升高是AMI患者发生MACE的保护因素(P<0.05).ROC曲线分析结果显示,血清AIM2、CDC42联合预测AMI患者发生MACE的曲线下面积(AUC)为0.901,高于AIM2、CDC42单独预测的AUC(Z=4.886、4.269,P<0.001).结论 AMI患者血清AIM2水平升高,CDC42水平降低,二者与AMI患者心功能Killip分级相关,血清AIM2、CDC42联合检测对AMI患者发生MACE具有较高的预测价值.
Predictive value of serum AIM2 and CDC42 combined detection for MACE in patients with acute myocardial infarction
Objective To analyze the predictive value of serum melanoma deficiency factor 2(AIM2)and cell division cyclin 42(CDC42)in the occurrence of major adverse cardiovascular events(MACE)in patients with acute myocardial infarction(AMI).Methods A total of 108 patients with AMI who underwent percuta-neous coronary intervention in Beijing Aerospace General Hospital from February 2019 to December 2021 were included in AMI group,and 60 healthy people who underwent physical examination in Beijing Aerospace General Hospital during the same period were selected as control group.Baseline data of patients were collect-ed,serum AIM2 and CDC42 levels were detected by Enzyme-linked immunosorbent assay,and AMI patients were followed up for 6 months.According to whether MACE occurred during the follow-up period,they were divided into MACE group and non-MACE group.Spearman correlation was used to analyze the correlation be-tween levels of serum AIM2,CDC42 and Killip grade of cardiac function in AMI patients.Multivariate Logistic regression was used to analyze the influencing factors of MACE in patients with AMI.Receiver operating char-acteristic(ROC)curve was plotted to analyze the predictive value of serum AIM2 and CDC42 for MACE alone and in combination in AMI patients.Results The level of AIM2 in AMI group was higher than that in control group,and the level of CDC42 in AMI group was lower than that in control group,and the differences were statistically significant(P<0.05).There were 29 patients in the MACE group and 79 patients in the non-MACE group.The serum AIM2 level in MACE group was higher than that in non-MACE group,and the ser-um CDC42 level in MACE group was lower than that in non-MACE group,with statistical significance(P<0.05).Compared with Killip grade Ⅰ-Ⅱ AMI patients,the serum AIM2 level in Killip grade Ⅲ-Ⅳ AMI patients was higher and the CDC42 level was lower,with statistical significance(P<0.05).Spearman correla-tion analysis showed that serum AIM2 level was positively correlated with Killip grade of cardiac function in AMI patients(rs=0.667,P<0.001),and serum CDC42 level was negatively correlated with Killip grade of cardiac function(rs=-0.712,P<0.001).Multivariate Logistic regression analysis showed that the increase of serum AIM2 level was an independent risk factor for MACE in AMI patients,and the increase of serum CDC42 level was a protective factor for MACE in AMI patients(P<0.05).ROC curve analysis results showed that the area under the curve(AUC)of AIM2 and CDC42 combined predicted MACE in AMI patients was 0.901,which was higher than the AUC of AIM2 and CDC42 alone(Z=4.886 and 4.269,P<0.001).Conclusion Serum AIM2 level increased and CDC42 level decreased in patients with AMI,both of which are correlated with Killip grade of cardiac function in patients with AMI.Serum AIM2 and CDC42 combined de-tection has a high predictive value for MACE occurrence in patients with AMI.

acute myocardial infarctionmelanoma deficiency factor 2cell division cyclin 42major adverse cardiovascular eventprognosis

李家镠、甘丰、权欣、裴娟慧、刘丽云、任芳、邢彦麟、卢宏泉

展开 >

北京航天总医院心内科,北京 100076

中国医学科学院阜外医院心内科,北京 100032

急性心肌梗死 黑色素瘤缺乏因子2 细胞分裂周期蛋白42 主要不良心血管事件 预后

2025

检验医学与临床
重庆市卫生信息中心 重庆市临床检验中心

检验医学与临床

影响因子:1.096
ISSN:1672-9455
年,卷(期):2025.22(1)